Kestra Advisory Services LLC Has $3.86 Million Holdings in Astera Labs, Inc. $ALAB

Kestra Advisory Services LLC increased its holdings in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) by 18.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,224 shares of the company’s stock after acquiring an additional 5,471 shares during the period. Kestra Advisory Services LLC’s holdings in Astera Labs were worth $3,861,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ALAB. Royal Bank of Canada raised its position in Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares during the last quarter. First Trust Advisors LP increased its stake in shares of Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. increased its stake in shares of Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after buying an additional 1,977 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other news, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. This trade represents a 11.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total value of $3,892,104.58. Following the transaction, the director owned 286,863 shares in the company, valued at approximately $131,492,261.94. This trade represents a 2.87% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,700,432 shares of company stock valued at $449,062,723 over the last 90 days. Company insiders own 10.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ALAB. Barclays upped their price target on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Stifel Nicolaus boosted their target price on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 target price on the stock. Susquehanna increased their price target on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Finally, JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $275.75.

Read Our Latest Research Report on Astera Labs

Astera Labs Stock Down 5.0%

Shares of ALAB stock opened at $303.62 on Friday. The firm has a market cap of $52.04 billion, a price-to-earnings ratio of 205.15, a PEG ratio of 3.60 and a beta of 3.66. Astera Labs, Inc. has a 12 month low of $96.79 and a 12 month high of $499.48. The stock has a 50-day moving average price of $349.32 and a 200 day moving average price of $220.59.

Astera Labs (NASDAQ:ALABGet Free Report) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s revenue was up 93.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 1.88 earnings per share for the current fiscal year.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.